Literature DB >> 6177534

Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.

C M Vos, G Westera.   

Abstract

The different forms of 57cobalt-bleomycin (57C0-blm) A2 and B2 as well as 57Co-pepleomycin (57Co-pep), were investigated in tumour-localizing properties of both forms of 57Co-blm are identical if 57Co-blm is injected as a bleomycin solution without carrier cobalt. Differences between the biological behaviour of the various cobalt complexes (which differ in ligand arrangement) were found if these complexes were injected together with inactive cobalt bleomycin complexes of the same form. In this case Co-blm B2 form I and Co-pep form I localize better than Co-blm b2 form II and Co-pep form II respectively. Such a decrease in uptake by the tumour, compared with form I, was not observed for Co-blm A2-II.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177534     DOI: 10.1007/BF00251652

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Chemical and biological properties of bleomycin labelled with 57Co.

Authors:  P Raban; J Brousil; P Svihovcová
Journal:  Eur J Nucl Med       Date:  1979-06-01

2.  BLEDTA: tumor localization by a bleomycin analogue containing a metal-chelating group.

Authors:  L H DeRiemer; C F Meares; D A Goodwin; C I Diamanti
Journal:  J Med Chem       Date:  1979-09       Impact factor: 7.446

3.  The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.

Authors:  C M Vos; G Westera; P J van der Jagt; B van Zanten
Journal:  Eur J Nucl Med       Date:  1979-10

4.  Comparison of growth characteristics of experimental tumours and derived cell cultures.

Authors:  G W Barendsen; H C Janse; B F Deys; C F Hollander
Journal:  Cell Tissue Kinet       Date:  1977-09

5.  Chemical properties and tumor affinity of separated isomers of cobalt-bleomycin.

Authors:  J Kakinuma; R Kagiyama; H Orii
Journal:  Eur J Nucl Med       Date:  1980-04

6.  Clinical evaluation of radio-labelled bleomycin for tumor detection.

Authors:  J J Rasker; H Beekhuis; M A van de Poll; A Versluis; H Jurjens; M G Woldring
Journal:  Nuklearmedizin       Date:  1978-12       Impact factor: 1.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.